Clinical Trial Update: Assessment of 18F-Florbetaben Whole-body PET for the Detection of Cardiac and Extracardiac Sites of Amyloid Deposits [NA]

View source ↗

Summary

Completed clinical trial assessing 18F-Florbetaben whole-body PET for detecting cardiac and extracardiac amyloid deposits.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis

Drugs mentioned

• 18F-Florbetaben

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Cardiac Amyloidosis | NA | Status: COMPLETED